Imaging movement-related activity in medicated Parkin-associated and sporadic Parkinson's disease

Parkinsonism and Related Disorders

Volumn 16, Issue 6, 2010, Pages 384-387

  van Eimeren, Thilo ^a   Binkofski, Ferdinand ^b   Buhmann, Carsten ^c   Hagenah, Johann ^b   Strafella, Antonio P ^a   Pramstaller, Peter P ^d   Siebner, Hartwig R ^e   Klein, Christine ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d INSTITUTE FOR RENEWABLE ENERGY   (Italy)

^e HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Dyskinesias; FMRI; Genetics; Motor control; Parkinsonism

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PARKIN;

ADULT; ARTICLE; BRAIN; DISEASE DURATION; DYSKINESIA; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MOVEMENT (PHYSIOLOGY); PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; TASK PERFORMANCE;

ADULT; AGED; BRAIN; BRAIN MAPPING; DYSKINESIAS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOVEMENT; MUTATION; PARKINSON DISEASE; UBIQUITIN-PROTEIN LIGASES;

EID: 77953618132     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.04.003     Document Type: Article

References (23)

1. Klein C., Lohmann-Hedrich K. Impact of recent genetic findings in Parkinson's disease. Curr Opin Neurol 2007, Aug, 20(4):453-464.
2. Khan N.L., Graham E., Critchley P., Schrag A.E., Wood N.W., Lees A.J., et al. Parkin disease: a phenotypic study of a large case series. Brain 2003, Jun, 126(Pt 6):1279-1292.
3. Klein C., Pramstaller P.P., Kis B., Page C.C., Kann M., Leung J., et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol 2000, Jul, 48(1):65-71.
4. Lohmann E., Periquet M., Bonifati V., Wood N.W., De Michele G., Bonnet A.M., et al. How much phenotypic variation can be attributed to Parkin genotype?. Ann Neurol 2003, Aug, 54(2):176-185.
5. Blanchet P.J., Allard P., Gregoire L., Tardif F., Bedard P.J. Risk factors for peak dose dyskinesia in 100 levodopa-treated Parkinsonian patients. Can J Neurol Sci 1996, Aug, 23(3):189-193.
6. Buhmann C., Binkofski F., Klein C., Buchel C., van Eimeren T., Erdmann C., et al. Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain 2005, Oct, 128(Pt 10):2281-2290.
7. Kloppel S., Vongerichten A., van Eimeren T., Frackowiak R.S., Siebner H.R. Can left-handedness be switched? Insights from an early switch of handwriting. J Neurosci 2007, Jul 18, 27(29):7847-7853.
8. Jahanshahi M., Jenkins I.H., Brown R.G., Marsden C.D., Passingham R.E., Brooks D.J. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995, Aug, 118(Pt 4):913-933.
9. Jenkins I.H., Fernandez W., Playford E.D., Lees A.J., Frackowiak R.S., Passingham R.E., et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 1992, Dec, 32(6):749-757.
10. van Eimeren T., Boecker H., Konkiewitz E.C., Schwaiger M., Conrad B., Ceballos-Baumann A.O. Right lateralized motor cortex activation during volitional blinking. Ann Neurol 2001, Jun, 49(6):813-816.
11. van Eimeren T., Wolbers T., Munchau A., Buchel C., Weiller C., Siebner H.R. Implementation of visuospatial cues in response selection. Neuroimage 2006, Jan 1, 29(1):286-294.
12. Buhmann C., Glauche V., Sturenburg H.J., Oechsner M., Weiller C., Buchel C. Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 2003, Feb, 126(Pt 2):451-461.
13. Haslinger B., Erhard P., Kampfe N., Boecker H., Rummeny E., Schwaiger M., et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001, Mar, 124(Pt 3):558-570.
14. Heuninckx S., Wenderoth N., Swinnen S.P. Systems neuroplasticity in the aging brain: recruiting additional neural resources for successful motor performance in elderly persons. J Neurosci 2008, Jan 2, 28(1):91-99.
15. Naccarato M., Calautti C., Jones P.S., Day D.J., Carpenter T.A., Baron J.C. Does healthy aging affect the hemispheric activation balance during paced index-to-thumb opposition task? An fMRI study. Neuroimage 2006, Sep, 32(3):1250-1256.
16. Riecker A., Groschel K., Ackermann H., Steinbrink C., Witte O., Kastrup A. Functional significance of age-related differences in motor activation patterns. Neuroimage 2006, Sep, 32(3):1345-1354.
17. Taniwaki T., Okayama A., Yoshiura T., Togao O., Nakamura Y., Yamasaki T., et al. Age-related alterations of the functional interactions within the basal ganglia and cerebellar motor loops in vivo. Neuroimage 2007, Jul 15, 36(4):1263-1276.
18. Eckert T., Tang C., Eidelberg D. Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 2007, Oct, 6(10):926-932.
19. Huang C., Tang C., Feigin A., Lesser M., Ma Y., Pourfar M., et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007, Jul, 130(Pt 7):1834-1846.
20. Obeso J.A., Rodriguez-Oroz M., Marin C., Alonso F., Zamarbide I., Lanciego J.L., et al. The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits. Neurology 2004 Jan 13, 62(1 Suppl. 1):S17-S30.
21. Brooks D.J. PET studies and motor complications in Parkinson's disease. Trends Neurosci 2000, Oct, 23(Suppl. 10):S101-S108.
22. de la Fuente-Fernandez R., Sossi V., Huang Z., Furtado S., Lu J.Q., Calne D.B., et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 2004, Dec, 127(Pt 12):2747-2754.
23. Brooks D.J., Piccini P., Turjanski N., Samuel M. Neuroimaging of dyskinesia. Ann Neurol 2000, Apr, 47(4 Suppl. 1):S154-S158. [discussion S8-S9].